Background: Kidney involvement is a common manifestation of the systemic autoimmune rheumatic diseases. Kidney biopsy is the gold standard for the diagnosis of kidney diseases, however this method has not yet become the standard-of-care in rheumatology practice.
Aim: To assess the diagnostic value of kidney biopsy in the management of patients of the rheumatology department.